Ryan Kilpatrick

Dr. Ryan Kilpatrick is the Vice President of Epidemiology and a Distinguished Research Fellow at AbbVie, where they lead a team focused on developing strategies using observational and real-world evidence to enhance drug development and assess the benefit-risk of therapies. They have a robust background in research, having earned a PhD in Epidemiology from UCLA and completed an interdisciplinary HIV/AIDS training grant. Dr. Kilpatrick previously held roles of increasing responsibility at Amgen and Baxalta US, Inc., and has contributed over forty peer-reviewed articles to clinical and specialty journals. Currently, they are studying Psychology at the University of Arizona.